Effect of erythromycin on biological activities induced by Clostridium perfringens α-toxin

Journal of Pharmacology and Experimental Therapeutics

Volumn 327, Issue 3, 2008, Pages 934-940

  Oda, Masataka ^a   Kihara, Atsushi ^a   Yoshioka, Hiroki ^a   Saito, Yuki ^a   Watanabe, Naoyuki ^a   Uoo, Kana ^a   Higashihara, Masahiro ^a   Nagahama, Masahiro ^a   Koide, Naoki ^b   Yokochi, Takashi ^b   Sakurai, Jun ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CLOSTRIDIUM TOXIN; ERYTHROMYCIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; K 252A; KITASAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE A; TRKA PROTEIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME INHIBITION; GAS GANGRENE; HEMOLYSIS; MOUSE; MYOSITIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIDOTES; BACTERIAL TOXINS; CALCIUM-BINDING PROTEINS; CYTOKINES; DRUG ANTAGONISM; ERYTHROMYCIN; HEMOLYSIS; MICE; NEUTROPHIL ACTIVATION; NEUTROPHILS; TYPE C PHOSPHOLIPASES;

EID: 57349137729     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.143677     Document Type: Article

References (39)

1. Aldridge AJ (2002) Role of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur J Surg 168:204-214.
2. Anderson R (1989) Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. J Infect Dis 159:966-973.
3. Bryant AE and Stevens DL (1996) Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells. Infect Immun 64:358-362.
4. Bunting M, Lorant DE, Bryant AE, Zimmerman GA, McIntyre TM, Stevens DL, and Prescott SM (1997) Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J Clin Invest 100:565-574.
5. Calandra T, Bochud PY, and Heumann D (2002) Cytokines in septic shock. Curr Clin Top Infect Dis 22:1-23.
6. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, and Trinchieri G (1995) Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J Exp Med 181:537-546.
7. Dinarello CA (2004) Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr Opin Pharmacol 4:378-385.
8. Fujii T, Kadota J, Kawakami K, Iida K, Shirai R, Kaseda M, Kawamoto S, and Kohno S (1995) Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax 50:1246-1252.
9. Hand WL, Hand DL, and King-Thompson NL (1990) Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob Agents Chemother 34:863-870.
10. Herbertson MJ, Werner HA, Goddard CM, Russell JA, Wheeler A, Coxon R, and Walley KR (1995) Anti-tumor necrosis factor-alpha prevents decreased ventricular contractility in endotoxemic pigs. Am J Respir Crit Care Med 152:480-488.
11. Kadota J, Sakito O, Kohno S, Sawa H, Mukae H, Oda H, Kawakami K, Fukushima K, Hiratani K, and Hara K (1993) A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 147:153-159.
12. Kanai K, Asano K, Hisamitsu T, and Suzaki H (2004) Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro. Mediators Inflamm 13:313-319.
13. Khan AA, Slifer TR, Araujo FG, and Remington JS (1999) Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int J Antimicrob Agents 11:121-132.
14. Kreidl KO, Green GR, and Wren SM (2002) Intravascular hemolysis from a Clostridium perfringens liver abscess. J Am Coll Surg 194:387.
15. Leirisalo-Repo M (1994) The present knowledge of the inflammatory process and the inflammatory mediators. Pharmacol Toxicol 75 (Suppl 2):1-3.
16. Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlöndorff J, Tempst P, Choi Y, and Blobel CP (1999) Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 274:13613-13618.
17. Nagahama M, Okagawa Y, Nakayama T, Nishioka E, and Sakurai J (1995) Site-directed mutagenesis of histidine residues in Clostridium perfringens alpha-toxin. J Bacteriol 177:1179-1185.
18. Ochi S, Hashimoto K, Nagahama M, and Sakurai J (1996) Phospholipid metabolism induced by Clostridium perfringens alpha-toxin elicits a hot-cold type of hemolysis in rabbit erythrocytes. Infect Immun 64:3930-3933.
19. Ochi S, Miyawaki T, Matsuda H, Oda M, Nagahama M, and Sakurai J (2002) Clostridium perfringens alpha-toxin induces rabbit neutrophil adhesion. Microbiology 148:237-245.
20. Ochi S, Oda M, Matsuda H, Ikari S, and Sakurai J (2004) Clostridium perfringens alpha-toxin activates the sphingomyelin metabolism system in sheep erythrocytes. J Biol Chem 279:12181-12189.
21. Oda M, Ikari S, Matsuno T, Morimune Y, Nagahama M, and Sakurai J (2006) Signal transduction mechanism involved in Clostridium perfringens alpha-toxin-induced superoxide anion generation in rabbit neutrophils. Infect Immun 74:2876-2886.
22. Oda M, Matsuno T, Shiihara R, Ochi S, Yamauchi R, Saito Y, Imagawa H, Nagahama M, Nishizawa M, and Sakurai J (2008) The relationship between the metabolism of sphingomyelin species and the hemolysis of sheep erythrocytes induced by Clostridium perfringens alpha-toxin. J Lipid Res 49:1039-1047.
23. Pålsson-McDermott EM and O'Neill LA (2004) Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113:153-162.
24. Riedemann NC, Guo RF, and Ward PA (2003) Novel strategies for the treatment of sepsis. Nat Med 9:517-524.
25. Rubin BK and Tamaoki J (2000) Macrolide antibiotics as biological response modifiers. Curr Opin Investig Drugs 1:169-172.
26. Sakurai J, Ochi S, and Tanaka H (1994) Regulation of Clostridium perfringens alpha-toxin-activated phospholipase C in rabbit erythrocyte membranes. Infect Immun 62:717-721.
27. Sakurai J, Nagahama M, and Oda M (2004) Clostridium perfringens alpha-toxin: characterization and mode of action. J Biochem 136:569-574.
28. Sato K, Suga M, Akaike T, Fujii S, Muranaka H, Doi T, Maeda H, and Ando M(1998) Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice. Am J Respir Crit Care Med 157:853-857.
29. Schmid EE (1971) The macrolide group of antibiotics: mode of action. Antibiot Chemother 17:52-66.
30. Simpson JL, Powell H, Boyle MJ, Scott RJ, and Gibson PG (2008) Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 177:148-155.
31. Stevens DL (2000) The pathogenesis of clostridial myonecrosis. Int J Med Microbiol 290:497-502.
32. Stevens DL and Bryant AE (1997) Pathogenesis of Clostridium perfringens infection: mechanisms and mediators of shock. Clin Infect Dis 25:S160-S164.
33. Sugahara T and Osaka A (1970) Two molecular forms of Clostridium perfringens alpha-toxin associated with lethal, hemolytic and enzymatic activities. Jpn J Med Sci Biol 23:61-66.
34. Titball RW (1997) Bacterial phospholipases. Trends Microbiol 5:265.
35. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, and Cerami A (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664.
36. Tsai WC, Rodriguez ML, Young KS, Deng JC, Thannickal VJ, Tateda K, Hershenson MB, and Standiford TJ (2004) Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. Am J Respir Crit Care Med 170:1331-1339.
37. Tzianabos AO, Russell PR, Onderdonk AB, Gibson FC 3rd, Cywes C, Chan M, Finberg RW, and Kasper DL (1999) IL-2 mediates protection against abscess formation in an experimental model of sepsis. J Immunol 163:893-897.
38. van Setten PA, Monnens LA, Verstraten RG, van den Heuvel LP, and van Hinsbergh VW (1996) Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 88:174-183.
39. Yoshimura A, Hara Y, Kaneko T, and Kato I (1997) Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria. J Periodontal Res 32:279-286.